Active filters:
Showing 325–336 of 442 results
SUSTANON 250
$34.44Rated 4.80 out of 5
(5 Reviews)
CHARACTERISTICS
ACTIVE HALF-LIFE 7-8 DAYS
CLASSIFICATION ANABOLIC STEROID
DOSAGE MEN 300-1500 MG/WEEK
ACNE YES
WATER RETENTION YES
HBR PERHAPS
HEPATOTOXICITY NO
AROMATIZATION YES
ACTIVE SUBSTANCE TESTOSTERONE DECANOATE, TESTOSTERONE ISOCAPROATE, TESTOSTERONE PHENYLPROPIONATE, TESTOSTERONE PROPIONATE
FORM 10 ML X 250 MG/ML
MANUFACTURER SIS LABS
SUSTANON 250 10ml VIAL
$29.52Rated 4.60 out of 5
(5 Reviews)
CHARACTERISTICS
ACTIVE HALF-LIFE 7-8 DAYS
CLASSIFICATION ANABOLIC STEROID
DOSAGE MEN 300-1500 MG/WEEK
ACNE YES
WATER RETENTION YES
HBR PERHAPS
HEPATOTOXICITY NO
AROMATIZATION YES
ACTIVE SUBSTANCE TESTOSTERONE DECANOATE, TESTOSTERONE ISOCAPROATE, TESTOSTERONE PHENYLPROPIONATE, TESTOSTERONE PROPIONATE
FORM 10 ML X 250 MG/ML
MANUFACTURER HILMA BIOCARE
SUSTANON 350
$31.98Rated 4.80 out of 5
(5 Reviews)
CHARACTERISTICS
ACTIVE HALF-LIFE 7-8 DAYS
CLASSIFICATION ANABOLIC STEROID
DOSAGE MEN 300-1500 MG/WEEK
ACNE YES
WATER RETENTION YES
HBR PERHAPS
HEPATOTOXICITY NO
AROMATIZATION YES
ACTIVE SUBSTANCE TESTOSTERONE DECANOATE, TESTOSTERONE ISOCAPROATE, TESTOSTERONE PHENYLPROPIONATE, TESTOSTERONE PROPIONATE
FORM 10 ML X 350 MG/ML
MANUFACTURER DRAGON PHARMA
Symdeko (tezacaftor / ivacaftor)
$39,418.95Rated 4.80 out of 5
(5 Reviews)
DISEASE INDICATIONS: Cystic Fibrosis
MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Symdeko is indicated for the treatment of patients with CF who have specific genetic mutations that are responsive to these medications. This combination therapy addresses the underlying cause of CF by improving the function of the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) protein, which is often dysfunctional in CF patients.
$39,418.95
Symkevi (tezacaftor/ivacaftor)
$5,729.85Rated 4.80 out of 5
(5 Reviews)
DISEASE INDICATIONS: Cystic Fibrosis
MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Symkevi is specifically designed to address the underlying genetic defect in individuals with CF who have specific responsive mutations.
$5,729.85
T3 (Liothyronine Sodium)
$22.15Rated 5.00 out of 5
(3 Reviews)
ACTIVE HALF-LIFE: 1 DAY
CLASSIFICATION: THYROID HORMONE
DOSAGE: 25-75 MCG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: YES
HEPATOXITY: NO
AROMATIZATION: NO
ACTIVE SUBSTANCE: LIOTHYRONINE SODIUM
FORM: 100 Tablets X 25 MCG
MANUFACTURER: DRAGON PHARMA
Tadamix (Tadalafil 20mg + Dapoxetine 60mg) Tablets
From $29.46Rated 4.68 out of 5
(47 Reviews)
Product: Tadamix 10x80mg
Active substance: Tadalafil 20mg + Dapoxetine 60mg
Manufacturer / Brand: Zenit Pharma
From $29.46
Tagrisso (Osimertinib)
$5,571.28Rated 5.00 out of 5
(5 Reviews)
DISEASE INDICATIONS: Lung Cancer
MANUFACTURER: AstraZeneca AB
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Therapeutic Goods Administration (TGA)
Medsafe (NZ)
Tagrisso has been a game-changer, specifically targeting EGFR (epidermal growth factor receptor) mutations, which are prevalent in a subset of NSCLC patients.
$5,571.28
Takhzyro (lanadelumab)
$14,055.70Rated 4.80 out of 5
(5 Reviews)
DISEASE INDICATIONS: Hereditary angioedema (HAE)
MANUFACTURER: Shire Pharmaceuticals
USAGE: Subcutaneous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Takhzyro (lanadelumab) is a prescription medication used to prevent attacks of hereditary angioedema (HAE) in people 2 years of age and older. HAE is a rare genetic disorder that causes episodes of swelling in the face, throat, abdomen, hands, and feet. These episodes can be life-threatening.
$14,055.70
Taltz (ixekizumab)
From $2,499.58Rated 5.00 out of 5
(4 Reviews)
DISEASE INDICATIONS: Psoriasis
MANUFACTURER: Eli Lilly Nederland B.V.
USAGE: Subcutaneous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Therapeutic Goods Administration (TGA)
Taltz (ixekizumab) is a prescription medication used to treat moderate to severe plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis in adults. It is a monoclonal antibody that works by blocking interleukin 17A (IL-17A), a cytokine that plays a key role in the development and progression of these inflammatory diseases.
From $2,499.58
TAMOL PLUS (Paracetamol) 150ml
From $13.22Rated 4.67 out of 5
(24 Reviews)
Raw Material: paracetamol
Manufacturer: Sandoz
Package: 150ml
From $13.22
Tarpeyo (budesonide)
$18,549.15Rated 4.80 out of 5
(5 Reviews)
Tarpeyo (budesonide) 4mg, an innovative and effective medication designed to manage inflammatory and autoimmune conditions with precision and efficacy. Each pack contains 120 capsules of Tarpeyo, providing a convenient and sustained treatment option for patients requiring long-term therapy.
$18,549.15
